Christina Coughlin
Fortune : 87 471 $ au 31/05/2026
Fortune : 87 471 $ au 31/05/2026
Christina Marie Coughlin currently works at Avacta Group Plc, as Chief Executive Officer & Executive Director from 2024.
Dr. Coughlin also formerly worked at Cytoimmune Therapeutics, Inc., as Chief Executive Officer & Director from 2021 to 2023, Rubius Therapeutics, Inc., as Chief Medical Officer from 2020 to 2021, Tmunity Therapeutics, Inc., as Chief Medical Officer from 2018 to 2019, and Immunocore Holdings Plc, as Chief Medical Officer from 2015 to 2018.
Dr. Coughlin received her doctorate degree from the University of Pennsylvania and undergraduate degree from Temple University (Pennsylvania).
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVACTA GROUP PLC 0,02 % | 05/06/2026 | 82 142 ( 0,02 % ) | 87 471 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AVACTA GROUP PLC | Directeur Général | 01/04/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Directeur Général | 18/07/2023 |
| RUBIUS THERAPEUTICS | Directeur Technique/Scientifique/R&D | 12/11/2021 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur Technique/Scientifique/R&D | 01/11/2019 |
| IMMUNOCORE HOLDINGS PLC | Directeur Technique/Scientifique/R&D | 01/07/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Immunocore Holdings Plc
Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national